ÂÜÀòÂÒÂ×

Jeff Thramann has worked in a variety of entrepreneurial roles since 2001. Jeff began their career as a Founder/Managing Partner of Boulder Neurosurgical Associates in 2001. In 2002, they founded Rocky Mountain Cyberknife, the first Cyberknife radiosurgery center in Colorado, which became one of the top three centers worldwide before it was sold to U.S. Radiosurgery in 2006. In 2005, they founded U.S. Radiosurgery, a venture-backed healthcare services company. In 2007, they founded ProNerve, a healthcare services company that provided monitoring of nerve function during high risk surgical procedures, which was sold to Waud Capital Partners in 2012. In 2003, they founded Lanx, a private equity-funded medical device company, which was sold to Biomet, Inc. in 2013. In 2011, they founded LT350, a clean energy company with six issued U.S. & International patents on a solar parking lot canopy. In 2019, they founded Influence Healthcare. In 2011, they founded Auddia (NASDAQ:AUUD), which is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts.

Jeff Thramann has an education history that includes attending the Joan & Sanford I. Weill Medical College of Cornell University, Barrow Neurological Institute, and the United States Military Academy at West Point.